Сверхфразовое единство и текст

и более самостоятельных предложений, объединённых общностью темы в смысловые блоки.

(высказываниями)


Компоненты высказывания - тема и рема (тема - данное, исходное; рема - новое, искомое).

аргументирующего, анализирующего типа), и высказывания верификативные, которые служат целям утверждения или опровержения,

контраргументации (высказывания полемические, убеждающие, воздействующие).

царя была дочь, невеста. Царевна далеко славилась и лицом и

умом, и потому многие весьма хорошие люди желали сосватать ее. Среди этих женихов были князья, воеводы, и гости торговые, и ловкие проходимцы, которые всегда толкаются в знатных домах и выискивают, чем бы услужить»(Н. Рерих. Детская сказка)

groups – protein, fat and carbohydrate. Of these, only refined

carbohydrate is reported to cause caries as it is the only food which can be turned into acid by the bacteria concerned. Refined carbohydrates are sugar and white flour, so anything containing these can give rise to carries. Such foods are cake, biscuits, bread, jam and sweets.

(СКИ),
в) содержательно-подтекстовую (СПИ)

будут происходить в окружающем нас мире, действительном или воображаемом.

СФИ, понимание их причинно-следственных связей, их значимости в социальной, экономической,

поли­тической, культурной жизни народа, включая отношения между отдель­ными индивидуумами, их сложного психологического и эстетико-познавательного взаимодействия.

единиц языка порождать ассоциативные и коннотативные значения, а также благодаря

способности предложений внутри СФЕ приращивать смыслы.

событиях происходящих, происшедших или которые будут происходить в ближайшее время.

природы, внешности персонажей, обстановки, ситуации, места действия и пр., в)

рассуждения автора;
2) чужая речь: а) диалог (с вкраплением авторских ремарок), б) цитация;
3) несобственно-прямая речь.

в дальнейшем развертываются в основном тексте; б) аннотация — перечисление

проблем, затронутых в основном тексте; в) прагматичность — описание целевой установки произведения; г) концептуальность — некоторые теоретические, мето­дологические и др. положения, которые легли в основу произведения; д) энциклопедичность — сведения об авторе и краткое описание работ в данной области, предшествующих данной работе и т.д.

последовательность, (темпоральную и/или пространственную) взаимозависимость отдельных сообщений, фактов, действий и

пр

выражения, относящие читателя к предшествующей содержательно-фактуальной информации.

яснее представить себе связь и об­условленность событий и эпизодов.

the following pages; we shall look further into some of

the theoretical differences... later in this chapter"

в целое, а также процесс, ведущий к такому состоянию.

to the progressive aging of the population, and the fact

that cardiovascular disease (CVD) is the leading cause of death among the elderly, the prevention of CVD in the elderly is becoming increasingly important. Although there is no doubt that statin treatment should be used for reducing CVD risk in the elderly in secondary prevention in the same way as in younger individuals, the evidence that such treatment really prolongs life in elderly subjects in primary prevention is still not so clear. However, it seems that it does reduce CVD morbidity in elderly individuals. Because of limited evidence regarding the benefit of such therapy, particularly in very old subjects (older than 80-85 years), the decision whether to treat or not treat an elderly individual with statins in primary prevention should be based on good clinical judgment and considering the individual subject's situation regarding comorbidities, polypharmacy, and possible adverse effects.

fact that cardiovascular disease (CVD) is the leading cause of

death among the elderly, the prevention of CVD in the elderly is becoming increasingly important. Although there is no doubt that statin treatment should be used for reducing CVD risk in the elderly in secondary prevention in the same way as in younger individuals, the evidence that such treatment really prolongs life in elderly subjects in primary prevention is still not so clear. However, it seems that it does reduce CVD morbidity in elderly individuals. Because of limited evidence regarding the benefit of such therapy, particularly in very old subjects (older than 80-85 years), the decision whether to treat or not treat an elderly individual with statins in primary prevention should be based on good clinical judgment and considering the individual subject's situation regarding comorbidities, polypharmacy, and possible adverse effects.

fact that cardiovascular disease (CVD) is the leading cause of

death among the elderly, the prevention of CVD in the elderly is becoming increasingly important. Although there is no doubt that statin treatment should be used for reducing CVD risk in the elderly in secondary prevention in the same way as in younger individuals, the evidence that such treatment really prolongs life in elderly subjects in primary prevention is still not so clear. However, it seems that it does reduce CVD morbidity in elderly individuals. Because of limited evidence regarding the benefit of such therapy, particularly in very old subjects (older than 80-85 years), the decision whether to treat or not treat an elderly individual with statins in primary prevention should be based on good clinical judgment and considering the individual subject's situation regarding comorbidities, polypharmacy, and possible adverse effects.

fact that cardiovascular disease (CVD) is the leading cause of

death among the elderly, the prevention of CVD in the elderly is becoming increasingly important. Although there is no doubt that statin treatment should be used for reducing CVD risk in the elderly in secondary prevention in the same way as in younger individuals, the evidence that such treatment really prolongs life in elderly subjects in primary prevention is still not so clear. However, it seems that it does reduce CVD morbidity in elderly individuals. Because of limited evidence regarding the benefit of such therapy, particularly in very old subjects (older than 80-85 years), the decision whether to treat or not treat an elderly individual with statins in primary prevention should be based on good clinical judgment and considering the individual subject's situation regarding comorbidities, polypharmacy, and possible adverse effects.

2 diabetes mellitus (T2DM) are major drivers of cardiovascular disease

(CVD). The link between environmental factors, obesity, and dysglycemia indicates that progression to diabetes with time occurs along a "continuum", not necessarily linear, which involves different cellular mechanisms including alterations of insulin signaling, changes in glucose transport, pancreatic beta cell dysfunction, as well as the deregulation of key genes involved in oxidative stress and inflammation. The present review critically addresses key pathophysiological aspects including (i) hyperglycemia and insulin resistance as predictors of CV outcome, (ii) molecular mechanisms underpinning the progression of diabetic vascular complications despite intensive glycemic control, and (iii) stratification of CV risk, with particular emphasis on emerging biomarkers. Taken together, these important aspects may contribute to the development of promising diagnostic approaches as well as mechanism-based therapeutic strategies to reduce CVD burden in obese and diabetic subjects.